JPMorgan Chase & Co vs Moderna, Inc. — how do they compare? JPMorgan Chase & Co trades at $344.78 (market cap $900.78B), while Moderna, Inc. trades at $59.38 (market cap $23.60B). The key difference: JPMorgan Chase & Co is far larger — about 38.2× Moderna, Inc.'s market cap, and JPMorgan Chase & Co pays a 1.77% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| JPM | MRNA | |
|---|---|---|
Market Cap | $900.78B | $23.60B |
Volume | 10,479,943 | — |
Sector | Financials | Health |
52-Week High | $346.91 | $81.80 |
52-Week Low | $282.84 | $22.36 |
Dividend Yield | 1.77% | — |
Enterprise Value | — | $19.70B |
Signals from Pluang's Aura AI — not financial advice
JPMorgan Chase & Co. (JPM) trades at $345.13, up 1.18% with a bullish technical signal and strong analyst consensus. Recent earnings show beats in Q1 and Q2 2026, with revenue growth from $181.85B in 2025 to $194.8B projected for 2026. The stock's P/E of 14.52 and net income margin of 33.4% reflect solid fundamentals, while institutional activity includes recent purchases by Florida Trust Wealth Management.
Outlook remains positive with a consensus price target of $372.73, though risks include geopolitical tensions and cybersecurity threats highlighted in recent news. Earnings growth and ROE leadership in the banking sector support upside potential, but investors should monitor cash flow volatility and macroeconomic headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →